Cargando…
Xanthine Oxidase and Uric Acid in Atrial Fibrillation
Autores principales: | Korantzopoulos, Panagiotis, Letsas, Konstantinos P., Liu, Tong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359524/ https://www.ncbi.nlm.nih.gov/pubmed/22654765 http://dx.doi.org/10.3389/fphys.2012.00150 |
Ejemplares similares
-
Atrial Fibrillation: Mechanisms and Management
por: Liu, Tong, et al.
Publicado: (2019) -
Xanthine Oxidase Inhibitor Allopurinol Prevents Oxidative Stress‐Mediated Atrial Remodeling in Alloxan‐Induced Diabetes Mellitus Rabbits
por: Yang, Yajuan, et al.
Publicado: (2018) -
Inflammation and atrial fibrillation: A comprehensive review
por: Korantzopoulos, Panagiotis, et al.
Publicado: (2018) -
A review on atrioventricular junction ablation and pacing for heart rate control of atrial fibrillation
por: Vlachos, Konstantinos, et al.
Publicado: (2015) -
Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysis
por: Zhang, Zhiwei, et al.
Publicado: (2017)